FDA Approves Onapgo - Drugs.com
Supernus will make Onapgo available in the second quarter of 2025 with a support team of experts, including a robust nurse education program, and access support at launch. …
Supernus Announces FDA Approval of ONAPGO™ (apomorphine …
1 day ago · Supernus Pharmaceuticals, Inc. ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced …
SPN-830, now Onapgo, approved for advanced Parkinson’s disease
2 days ago · Long road to Onapgo’s approval. Despite these demonstrated benefits, Supernus has faced challenges in getting the therapy approved by the FDA. The company first applied …
FDA approves Supernus’ Onapgo to treat advanced Parkinson’s …
15 hours ago · The US Food and Drug Administration (FDA) has approved Supernus Pharmaceuticals’ Onapgo (apomorphine hydrochloride) injection to treat motor fluctuations in …
Supernus Announces FDA Approval of ONAPGO ... - Markets Insider
1 day ago · 1 ONAPGO. Package insert. Supernus Pharmaceuticals, Inc. *Efficacy results from the analysis of data from the TOLEDO study using the FDA’s preferred methodology, mixed …
Supernus Pharmaceuticals Announces FDA Approval of ONAPGO, …
1 day ago · Supernus will make ONAPGO available in the second quarter of 2025 with a support team of experts, including a robust nurse education program, and access support at launch.
U.S. FDA approves Supernus' drug-device combination for …
1 day ago · The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the …
FDA Approves Apomorphine Infusion Device SPN-830 as New …
2 days ago · Nearly 4 and a half years since its original submission, the FDA has approved Supernus Pharmaceuticals’ investigational agent SPN-830 (Onapgo) as the first and only …
Supernus' Parkinson's pump Onapgo finally lands FDA approval
1 day ago · Onapgo is a wearable pump designed to provide a continuous subcutaneous infusion of Supernus’ apomorphine (Apokyn). ... Supernus’ Apokyn contributed $19.9 million to the …
Supernus Gets FDA Approval of Onapgo Device for Parkinson's …
1 day ago · Supernus said Onapgo is a wearable infusion device that provides continuous treatment during the waking day for more consistent control of off periods, which can occur in …
- Some results have been removed